Literature DB >> 11854472

Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia.

Hyo Chol Ha1, Lynda D Hester, Solomon H Snyder.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1, EC ), a nuclear enzyme activated by DNA strand breaks, physiologically participates in DNA repair. Excessive activation of PARP-1 by cellular insults depletes its substrate beta-nicotinamide adenine dinucleotide and ATP, leading to cell death. PARP-1-deficient (PARP-1-/-) mice are protected from several forms of inflammation. In the present study, we demonstrate in PARP-1-/- glial cells a loss of several stress-activated transcription factors as well as decreased expression of genes for cytokines and cellular adhesion molecules. We also show that augmented expression of some of these genes is independent of PARP-1 catalytic activity. These findings indicate that PARP-1 plays a pivotal role in the initial inflammatory response by modulating transcription of inflammation-linked genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854472      PMCID: PMC122508          DOI: 10.1073/pnas.052712399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Microglia in cell culture and in transplantation therapy for central nervous system disease.

Authors:  K Dobrenis
Journal:  Methods       Date:  1998-11       Impact factor: 3.608

Review 2.  IkappaB-NF-kappaB structures: at the interface of inflammation control.

Authors:  P A Baeuerle
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

3.  Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice.

Authors:  S Kühnle; P Nicotera; A Wendel; M Leist
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

4.  Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

Authors:  M Masutani; H Suzuki; N Kamada; M Watanabe; O Ueda; T Nozaki; K Jishage; T Watanabe; T Sugimoto; H Nakagama; T Ochiya; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.

Authors:  A A Pieper; D J Brat; D K Krug; C C Watkins; A Gupta; S Blackshaw; A Verma; Z Q Wang; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase.

Authors:  J Nie; S Sakamoto; D Song; Z Qu; K Ota; T Taniguchi
Journal:  FEBS Lett       Date:  1998-03-06       Impact factor: 4.124

Review 7.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.

Authors:  C Szabó; V L Dawson
Journal:  Trends Pharmacol Sci       Date:  1998-07       Impact factor: 14.819

8.  PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation.

Authors:  P Kannan; Y Yu; S Wankhade; M A Tainsky
Journal:  Nucleic Acids Res       Date:  1999-02-01       Impact factor: 16.971

9.  Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers.

Authors:  W M Shieh; J C Amé; M V Wilson; Z Q Wang; D W Koh; M K Jacobson; E L Jacobson
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription.

Authors:  A J Butler; C P Ordahl
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  91 in total

1.  Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Authors:  Viktor R Drel; Pal Pacher; Martin J Stevens; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2006-01-31       Impact factor: 7.376

Review 2.  Mechanisms of vascular aging: new perspectives.

Authors:  Zoltan Ungvari; Gabor Kaley; Rafael de Cabo; William E Sonntag; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-24       Impact factor: 6.053

Review 3.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

Authors:  Irina G Obrosova; Pal Pacher; Csaba Szabó; Zsuzsanna Zsengeller; Hiroko Hirooka; Martin J Stevens; Mark A Yorek
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

5.  Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.

Authors:  Tiina M Kauppinen; Wai Y Chan; Sang Won Suh; Amanda K Wiggins; Eric J Huang; Raymond A Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

6.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

Review 7.  Endothelial dysfunction and angiogenesis impairment in the ageing vasculature.

Authors:  Zoltan Ungvari; Stefano Tarantini; Tamas Kiss; Jonathan D Wren; Cory B Giles; Courtney T Griffin; Walter Lee Murfee; Pal Pacher; Anna Csiszar
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

8.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

9.  Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.

Authors:  Viktor R Drel; Pal Pacher; Igor Vareniuk; Ivan A Pavlov; Olga Ilnytska; Valeriy V Lyzogubov; Seth R Bell; John T Groves; Irina G Obrosova
Journal:  Int J Mol Med       Date:  2007-12       Impact factor: 4.101

Review 10.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.